20/09/2025
> *Update in the Treatment of Tuberculosis*
¶ How Will you treat *Drug Susceptible* Tuberculosis?
In 2025 TB *management module*, we have three treatment regimens for Drug susceptible Tuberculosis ie
¬ *6 months Regimen* ( the Classic one)
¬ *4 months regimen* ( this is New one and has received strong recommendations in recent guidelines. It's applicable for 3 months age onwards)
¬ *4 months new regimen* ( added in 2025 guidelines, and is applicable for age 12 years and above)
¶ Who should recieve *4 months* and who should receive *6 months* regimen ❓
¬ Nonsevere drug-susceptible TB » Prefer 4months regimen ie 2HRZE/2HR
¬ Those who do not meet the criteria for non-severe TB, should recieve *standard 6* months regimen. 2HRZE/4HR.
¶ What is *non-severe TB* according to 2025 guidelines ❓
Non-severe TB is defined as: Peripheral *lymph node* TB; intrathoracic lymph node TB without airway obstruction; *uncomplicated* TB pleural effusion or paucibacillary, non-cavitary disease, confined to one lobe of the lungs, and *without* a miliary pattern.
¶ What is *new 4 months* regimen ❓
Patient age 12 years or older, with drug susceptible Tuberculosis may recieve 4 drugs regimen of, Isoniazide, *Rifapentin*, Moxifloxacin and Pyrazinamide ie (2 HPMZ/2HPM)
¶ What should be the *duration* of treatment for *Severe Acute Malnutrition* with TB disease ❓
As *SAM* is defined as *danger sign*, children with SAM and non-severe TB should preferably receive *6 months* of TB treatment.
¶ How will you treat patient of *Congenital TB* ❓
Infants aged 0–3 months with suspected or confirmed Pul TB or tuberculous peripheral lymphadenitis should be treated with the *six-month* treatment regimen (2HRZE/4HR),
¶ How will you treat patient of *HIV having* Tuberculosis ❓
Those patients having *HIV and concomitant TB disease*, should recieve same duration of TB treatment as HIV negative patients.
ART should be started as soon as possible, within *2 weeks* of initiating ATT regardless of CD4 count.
Remeber that;
In case of *TBM*, delay ART initiation for at least *4 to 8 weeks* after starting ATT.
¶ How will you treat *Extra pulmonary* TB?
( Note: in new guidelines, there's no separate chapter dedicated to severe forms of TB disease like meningitis, arthritis etc, so we are going to keep the old durations, untill and unless we recieve updates)
First we will divide it into two groups.
¬ Ext Pulmonary TB (most forms, including cervical lymphadenopaghy) treated exactly the way we treat Pulmonary TB ie. 6 months regimen 2HRZE/4HR
¬ Ext Pul TB that's treated with 09 to 12 months regimen (2HRZE/10HR) . We memorize it with Mnemonic *ABCD*
*A*» Articular TB (Joint)
*B*» Bones TB
*C*» CNS TB
*D*» Disseminated TB.
So *ABCD = 09-12* months treatment
¶ How will you treat *Drug Resistant* TB?
We have multiple regimens tailored according to patient status. Let's discuss each......
¬ Isolated *Isoniazid resistant* «»
In patients with confirmed *rifampicin-susceptible, isoniazid-resistant* tuberculosis , treatment with rifampicin, ethambutol, pyrazinamide and levofloxacin is recommended for a *duration of 6 months*.
*Key notes*: Just replace Isonizide with Levoflxacin
¬ *Rifampin Resistant or Multi drug resistant ie MDR/RR-TB*
In children with MDR/RR-TB who's age is below 6 years, an *all-oral treatment regimen containing bedaquiline* may be used.
All *Oral 09-months Regimen* «» WHO suggests the use of the *9-month all-oral regimen* in patients with *MDR/RR-TB* and in whom resistance to *fluoroquinolones* has been excludeded.
The regimen can be Memorized with Mnemonic
*Close BELIEP*
*C* lofazimine (just for *4* months)
*B* edaquiline (just for *6* months )
*E* thambutol
*L* evoflxacin
*I* sonizide
*E* thionamide
*P* yranzenamide (for *5* months)
¶ How will you start *antiretroviral therapy* in patients on MDR/ RR-TB regimens ❓
Antiretroviral therapy is recommended for all patients with *HIV and drug-resistant* tuberculosis requiring second-line antituberculosis drugs, irrespective of CD4 cell count, as early as possible (within the *first 8 weeks*) following initiation of antituberculosis treatment.
¶ How will you treat *Hepatitis C* positive patient having concomitant Drug resistant TB disease ❓
In patients with MDR/RR-TB and HCV co-infection, WHO suggests the co-administration of HCV and TB treatment.
¶ How will you manage *MDR* with additional Floroquinolones resistannce ❓
¬ MDR with Additional *Floroquinolone resistance* «»
WHO suggests the use of a 6-month treatment regimen composed of bedaquiline, delamanid, linezolid, levofloxacin, and clofazimine in MDR/RR-TB patients *with or without fluoroquinolone* resistance.
¶ What is BPaLM Regimen ❓ *BPaLM* regimen ie *B* edaquilin,
*P* retomanid and
*L* inezolid,
*M* oxifloxacin used for 6 months in case of drug resistant TB. If Floroquinolones resistance is identified. Drop moxifloacin and continue the *BPaL* regimen.
(BPaLM is recommended for >14yrz old patients)
¶ what's duration of treatment for a *longer* regimen ❓
MDR/RR-TB patient on longer regimen, a total duration of *18 to 20* months is suggested. This regimen mainly applies to TBM and severe extra pulmonary TB disease.
¶ How to *make a regimen for longer duration* ❓
Combine the drugs to make *a regimen of at least 4* drugs, for example.......
*Regimen one* : all 3 group A drugs plus one group B drug so
4 drug regimen = 3A + 1B
*Regimen two* : if only 2 group A drugs used then add 2 drugs from group B, so our regimen = 2A+2B
*If Group A or Group B* drugs can't complete regimen, add drugs from group C e.g
*4 drug Regimen* = 1A+1B+2C
¶ What are *drug groups* for MDR TB?
¬ Group A (*LLB*, Linezolid, Levofloxacin, Bedaquiline : U Can replace Levoflxacin with Moxifloxacin) b
¬ Group B (*CC*, Clofazimine, Cycloserine)
¬ Group C (All the remaining drugs) .
¶ What is *WHO definition* of severe MDR TB?
Severe MDR-TB = cavities or bilateral parenchymal disease on chest radiography or extrapulmonary forms of disease other than Lymphadenopathy.
¶ Who should receive *steroids* ?
*PETS* should receive steroids (Initial adjuvant corticosteroid therapy with dexamethasone or prednisolone tapered over 6–8 weeks should be used. Remember that In new 2025 guidelines there's emphasis specifically on TBM & Pericarditis.)
1.*P* Pericarditis
2.*E* ndobronchial tuberculosis
3.*T* BM
4.*S* evere miliary tuberculosis
> *Regards. Dr Tanveer*